GetTopicDetailResponse(id=a524124690b6, topicName=瑞康曲妥珠單抗, introduction=, content=肺癌 瑞康曲妥珠單抗, image=null, comments=0, allHits=262, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Feb 28 10:56:02 CST 2025, time=2025-02-28, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=502029, tagList=[TagDto(tagId=502029, tagName=瑞康曲妥珠單抗)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2253985, encodeId=d7c022539852f, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=a524124690b6' target=_blank style='color:#2F92EE;'>#瑞康曲妥珠單抗#</a>, objectTitle=97%患者腫瘤縮小，疾病控制率達99%！上海市胸科醫(yī)院陸舜團隊領銜：ADC為肺癌患者帶來新選擇, objectType=article, longId=864397, objectId=d0df86439e3b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241230/1735552536799_8538692.png, objectUrl=/article/show_article.do?id=d0df86439e3b, replyNumber=0, likeNumber=42, createdTime=2025-02-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d0df86439e3b, moduleTitle=97%患者腫瘤縮小，疾病控制率達99%！上海市胸科醫(yī)院陸舜團隊領銜：ADC為肺癌患者帶來新選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d0df86439e3b)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-28發(fā)表于陜西省
